Efficacy of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus That of 7-Valent PCV (PCV7) Against Nasopharyngeal Colonization of Antibiotic-NonsusceptibleStreptococcus pneumoniae

Impact of 13-valent pneumococcal conjugate vaccine on otitis media bacteriology

(2014) Alice S. Zhao et al.   INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY

Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial

(2013) Ron Dagan et al.   CLINICAL INFECTIOUS DISEASES

Geographic and Temporal Trends in Antimicrobial Nonsusceptibility in Streptococcus pneumoniae in the Post-vaccine era in the United States

(2013) Ruth Link-Gelles et al.   JOURNAL OF INFECTIOUS DISEASES

PCV13 Impact Evaluations

(2013) Katherine L. O’Brien   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine

(2013) Sheldon L. Kaplan et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Infants, Children, and Adolescents

(2013) Greg L. Plosker   PEDIATRIC DRUGS

Dynamics of pneumococcal nasopharyngeal carriage in healthy children attending a day care center in northern Spain. influence of detection techniques on the results

(2012) María Ercibengoa et al.   BMC INFECTIOUS DISEASES

The fundamental link between pneumococcal carriage and disease

(2012) Birgit Simell et al.   Expert Review of Vaccines

Impact of 13-valent Pneumococcal Conjugate Vaccine on Pneumococcal Nasopharyngeal Carriage in Children With Acute Otitis Media

(2012) Robert Cohen et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Impact of Introduction of Conjugate Vaccines in the Vaccination Schedule on the Incidence of Pediatric Invasive Pneumococcal Disease Requiring Hospitalization in Madrid 2007 to 2011

(2012) Juan Picazo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The relationship between pneumococcal serotypes and antibiotic resistance

(2012) Jae-Hoon Song et al.   VACCINE

Pneumonia Due to Drug-Resistant Streptococcus pneumoniae

(2012) Sadao Jinno et al.   Current Infectious Disease Reports

Prevention of Antibiotic-Nonsusceptible Streptococcus pneumoniae With Conjugate Vaccines

(2011) L. M. Hampton et al.   JOURNAL OF INFECTIOUS DISEASES

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A

(2011) David Cooper et al.   VACCINE

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

(2011) Elizabeth Miller et al.   VACCINE

A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children

(2010) Carlos G Grijalva et al.   CURRENT OPINION IN PEDIATRICS

Pneumococcal disease caused by serotype 19A: Review of the literature and implications for future vaccine development

(2010) Rene Reinert et al.   VACCINE

Introduction and Proliferation of Multidrug‐ResistantStreptococcus pneumoniaeSerotype 19A Clones That Cause Acute Otitis Media in an Unvaccinated Population

(2009) Ron Dagan et al.   JOURNAL OF INFECTIOUS DISEASES

Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children

(2009) S. S. Huang et al.   PEDIATRICS